Press release
United States Helicobacter H. Pylori Infection Therapeutics Industry Intelligence Report 2025 | Growth, Opportunities & Key Drivers
Helicobacter H. Pylori Infection Therapeutics Industry
Akums Drugs and Pharmaceutical launched its latest formulation, Combikit (Amoxicillin + Clarithromycin + Esomeprazole). Approved by the Central Drugs Standard Control Organisation (CDSCO), this combination is indicated for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) and for the eradication of H. pylori in patients with active or healed peptic ulcers.
Par, an Endo company, launched the first generic version of Allergan's Pylera (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules. Combined with omeprazole, it is used to treat H. pylori infections and active or historical duodenal ulcers to eradicate the bacteria.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/helicobacter-pylori-infection-therapeutics-market?kb
FDA Approvals
Phathom Pharmaceuticals, Inc. received FDA approval for the reformulated vonoprazan tablets in VOQUEZNA TRIPLE PAK and DUAL PAK for treating H. pylori infections in adults. These regimens combine antibiotics with vonoprazan, the first new U.S. acid suppressant class in over 30 years.
With H. pylori infections affecting 30-40% of the U.S. population, often acquired in childhood, rising prevalence driven by lifestyle, socioeconomic factors, and healthcare access is expected to increase demand for effective therapeutics. The infection can cause gastritis or peptic ulcers in some individuals.
List of Top Key Player:
Phathom Pharmaceuticals, Akums Drugs & Pharmaceuticals Ltd., RedHill Biopharma Ltd., Cumberland Pharmaceuticals Inc., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Pernix Therapeutics LLC, Astellas Pharma Inc., Faromed Lifesciences LLP and Matrix Pharma among others.
Forecast Projection:
The Global Helicobacter Pylori Infection Therapeutics Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Market Intelligence Research Process:
The Helicobacter Pylori Infection Therapeutics Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=helicobacter-pylori-infection-therapeutics-market
Key Segmentation:
Antibiotics held about 59.6% of H. pylori market share
By Disease Type: (Type I H. Pylori, Type II H. Pylori)
By Therapeutics: (Antibiotics (Amoxicillin, Clarithromycin (Biaxin), Metronidazole (Flagyl), Tetracycline, Others), Proton Pump Inhibitors (PPIs) (Lansoprazole (Prevacid), Omeprazole (Prilosec), Pantoprazole (Protonix), Rabeprazole (Aciphex), Esomeprazole (Nexium), Others), Histamine (H-2) Blockers, Stomach-Lining Protectors, Bismuth Subsalicylate, Others)
By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Global Growth Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Helicobacter Pylori Infection Therapeutics Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.
Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.
Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.
Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.
Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.
Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.
Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.
Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/helicobacter-pylori-infection-therapeutics-market?kb
FAQ's
Q1: How fast is the Helicobacter Pylori Infection Therapeutics Market expected to grow in the coming years?
A: The market is forecast to expand at a robust High CAGR between 2025 and 2032, signaling strong global growth and investment potential.
Q2: Which regions are dominating the Helicobacter Pylori Infection Therapeutics Market and which are fastest-growing?
A: North America holds around 42.5% of market share
Q3: What factors are fueling the Helicobacter Pylori Infection Therapeutics Market's growth across regions?
A: Growth is propelled by increasing demand, strategic initiatives by key players, and untapped opportunities in emerging markets, helping companies maximize revenue potential.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Helicobacter H. Pylori Infection Therapeutics Industry Intelligence Report 2025 | Growth, Opportunities & Key Drivers here
News-ID: 4203219 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Power Transistor Market (2026-2033)., North America's Hold 32% Mar …
Market Size and Growth
Global power transistor market grows with rising demand in EVs, industrial electronics, and renewable energy (2026-2033)
United States: Recent Industry Developments
✅ February 2026: Infineon Technologies (U.S. operations) introduced next-generation silicon carbide (SiC) power transistors for EV and renewable energy applications.
✅ January 2026: ON Semiconductor launched high-efficiency gallium nitride (GaN) power transistors for data centers and industrial automation.
✅ December 2025: Texas Instruments released new automotive-grade MOSFETs to enhance power…
United States International Express Delivery Market (2026-2033)., North America …
Market Size and Growth
Market expansion outlook: The International Express Delivery Market was hit huge Growth (2026-2033)
United States: Recent Industry Developments
✅ February 2026: FedEx expanded its global express delivery network, introducing faster cross-border services for e-commerce shipments.
✅ January 2026: UPS launched AI-enabled route optimization to improve delivery speed and reduce operational costs.
✅ December 2025: DHL implemented sustainable delivery solutions using electric cargo vehicles for urban international shipments.
Downlaod Free Custom Research: https://www.datamintelligence.com/custom-research?kb=ied
Japan:…
United States Fibrin Sealants Market Witness high Growth (2026-2033)., North Ame …
Market Size and Growth
Fibrin Sealants Market to hit at a high CAGR during the forecast period (2026-2033)
United States: Recent Industry Developments
✅ February 2026: Baxter International launched a next-generation fibrin sealant with enhanced adhesive strength for surgical applications.
✅ January 2026: Medtronic expanded distribution of its fibrin sealant portfolio to support minimally invasive and robotic surgeries.
✅ December 2025: Integra LifeSciences introduced a fast-acting fibrin sealant optimized for wound closure in cardiovascular procedures.
Download…
United States Commercial Juicer Market (2026-2033) | Global Market Growth Projec …
Market Size and Growth
commercial juicer market reached US$ 1,865.34 Million in 2024, rising to US$ 1,958.40 Million in 2025 and is expected to reach US$ 3,058.87 Million by 2033, growing at a strong CAGR of 5.8% during the forecast period from 2026 to 2033.
demand is driven by investments in modern processing technologies, such as the US$ 6.3 million funding provided by the government to Greenhouse Juice Company in Mississauga, Canada.
United…
More Releases for Pylori
Helicobacter Pylori (H. Pylori) Market Trends, Treatment Landscape, and Forecast
Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects the stomach lining, leading to a variety of gastrointestinal disorders, including peptic ulcers, chronic gastritis, and gastric cancer. It is estimated that more than half of the world's population is infected with H. pylori, although many people remain asymptomatic. When symptomatic, H. pylori infections can cause stomach pain, bloating, nausea, and more severe complications like bleeding ulcers or gastric cancer.…
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Is Booming So Rapidl …
HTF MI just released the Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Abbott Laboratories,…
Helicobacter pylori (H. pylori) Infections Market is expected to reach $9.1 bill …
Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that colonizes the stomach lining, causing chronic gastritis, peptic ulcers, and significantly increasing the risk of gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. It affects nearly half of the global population, though prevalence varies by geography, socioeconomic conditions, and sanitation levels.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71739
Management of H. pylori infections typically relies on antibiotic-based eradication therapies, combined…
Helicobacter pylori H. pylori Diagnostics Market Is Set to Experience Revolution …
The Helicobacter pylori (H. pylori) diagnostics Market was valued at USD 554.46 million in 2021. It is expected to increase from USD 587.68 million in 2022 to USD 953.25 million by 2030, with a compound annual growth rate (CAGR) of 6.01% during the forecast period of 2023-2030.The popularity of H. pylori diagnostics is growing due to its benefits in improving diagnosis, enabling effective treatment, and reducing healthcare costs.
Detecting H. pylori…
Helicobacter Pylori (H Pylori) Non-Invasive Testing Market Share, Size, Demand, …
Helicobacter Pylori (H Pylori) Non-Invasive Testing Market size was valued at over USD 447 million in 2022. Driven by the increasing instances of peptic ulcers, the market is slated to register over 6.5% CAGR from 2023 to 2032. The Helicobacter Pylori (H. Pylori) Non-invasive Testing market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Helicobacter Pylori (H. Pylori) Non-invasive Testing market.…
Helicobacter pylori (H. pylori) Diagnostics Market to Witness Exponential Growth …
Helicobacter pylori (H. pylori) is a spiral shaped gram-negative aerobic bacterium commonly found in the stomach. Bacteria plays a vital role in balancing stomach ecology. When H. pylori invades and attacks the stomach lining, it causes stomach infections. These infections are commonly found in both men as well as women. Nearly 30% of the world's population is infected by H. pylori. In some countries, the bacteria infects more than 50%…
